Skip to main content
MRKR logo

MRKR · Marker Therapeutics, Inc. · Analyst Estimates

Track MRKR — free
$1.09 -0.23 (-17.42%) At close · Nov 20 Q1 2021 earnings call transcript
Market Cap
$18.17M
Shares
16.67M
Volume · Nov 20 1.97M Avg daily vol (3M) 703.97K

Analyst Estimates

Compare analyst forecasts for Marker Therapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Pull consensus estimates through the analyst estimates API or MCP →

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians. An EPS figure names its accounting basis, GAAP or Non-GAAP, where the capture records one, and compares only with the company's EPS on that basis; without one, the basis is not recorded.

Captured 2026-11-21 16:05 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD · Non-GAAP
Publication date not stated
-0.51
-0.50
-0.48
2
-0.57
-0.57
-0.57
-0.57
0
0
2
2
Revenue
USD
Publication date not stated
4.00M
4.09M
4.17M
2
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD · Non-GAAP
Publication date not stated
-0.54
-0.36
-0.18
2
-0.53
-0.53
-0.53
-0.53
0
0
1
1
Revenue
USD
Publication date not stated
10.20M
22.02M
32.86M
3
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD · Non-GAAP
Publication date not stated
-0.15
-0.14
-0.12
2
-0.17
-0.17
-0.17
-0.17
0
0
0
0
Revenue
USD
Publication date not stated
1.45M
1.45M
1.45M
1
— — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD · Non-GAAP
Publication date not stated
-0.15
-0.15
-0.15
1
-0.22
-0.22
-0.22
-0.22
0
0
1
1
Revenue
USD
Publication date not stated
1.80M
1.80M
1.80M
1
— — — — — — — —
Key facts CIK 1094038 CUSIP 57055L206 13F (30d) 51 filings 34 filers Visit website Investor relations